Abingdon Health Plc (LON:ABDX – Get Free Report) traded up 6% during mid-day trading on Wednesday . The company traded as high as GBX 8.75 ($0.11) and last traded at GBX 8.75 ($0.11). 15,850 shares changed hands during trading, a decline of 93% from the average session volume of 223,908 shares. The stock had previously closed at GBX 8.25 ($0.11).
Abingdon Health Stock Up 6.0 %
The firm has a market cap of £16.57 million, a PE ratio of -899.00 and a beta of 0.13. The business’s 50 day moving average price is GBX 9.47 and its 200 day moving average price is GBX 10.15. The company has a debt-to-equity ratio of 46.64, a current ratio of 1.95 and a quick ratio of 1.96.
About Abingdon Health
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Featured Stories
- Five stocks we like better than Abingdon Health
- What Makes a Stock a Good Dividend Stock?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Stock Splits, Do They Really Impact Investors?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- 5 discounted opportunities for dividend growth investors
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
